One in three cancer articles on social media has wrong infoAugust 4, 2021Lung CancerBreast CancerGenitourinary CancerMelanoma
Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerCancerOncology
Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX TherapyMay 12, 2021Genitourinary CancerOncology
The power and promise of social media in oncologyMay 3, 2021Breast CancerGenitourinary CancerLung CancerMelanomaOncology
Success in LGBTQ+ medicine requires awareness of riskApril 30, 2021Genitourinary CancerOncologyInfectious DiseasesHIVSexual Health
To stay: Two more cancer indications with ‘dangling approvals’April 29, 2021Genitourinary CancerOncology
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Multiple MyelomaBreast CancerGenitourinary CancerLung CancerOncology
Healthy lifestyle may offset genetic risk in prostate cancerApril 13, 2021Genitourinary CancerOncologyProstate Cancer
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Lung CancerBreast CancerCOVID-19 UpdatesMixed TopicsGenitourinary CancerMultiple MyelomaOncology
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Breast CancerGenitourinary CancerLung CancerMultiple MyelomaOncologyHealth Policy
Surveillance after testicular cancer: New approaches slash radiation exposureFebruary 25, 2021Genitourinary CancerOncology
How has the pandemic affected rural and urban cancer patients?February 18, 2021Breast CancerCOVID-19 UpdatesGenitourinary CancerLung CancerMelanomaOncology
CCR score can guide treatment decisions after radiation in prostate cancerFebruary 13, 2021Genitourinary CancerProstate CancerOncology
Liquid vs. tissue biopsy in advanced prostate cancer: Why not both?February 12, 2021Genitourinary CancerOncology
